Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2025-12-26 @ 1:01 AM
Study NCT ID:
NCT03414034
Status:
COMPLETED
Last Update Posted:
2024-11-07
First Post:
2018-01-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Cardiff Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-16
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-22
First Submit QC Date:
None
Study First Post Date:
2018-01-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-15
Results First Submit QC Date:
None
Results First Post Date:
2024-11-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-15
Last Update Post Date:
2024-11-07
Last Update Post Date Type:
ACTUAL